ARCHIVES

CMS Considering Regulatory Standards for Drug Company Bundling of Products.

This article is from The Cancer Letter archive.

Vol. 32 No. 37 | October 20, 2006

Download PDF Visit The Full Archive

Related Articles

Shubik Named To Another NCA Term In Surprise Move

June 25, 1976

OSI Underestimated Magnitude Of Gallo Case: Hadley

February 3, 1995

In Brief: MSK Opens Campaign On Colorectal Cancer Early Detection NIH Symposium Dedicates Cyclotron

August 28, 1987

In Brief: Thomas, Murray share Nobel Prize for Medicine; Wynder To Present Carese Memorial Lecture

October 12, 1990

FDA will return memento given to McClellan by NCI Director Andrew von Eschenbach.

February 6, 2004

STAR Begins: Critics of Trial Call For Including A Placebo Arm

June 4, 1999